Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
Counterfeits: Opportunities for MEDICRIME, Challenges for IMPACT
07 July 2010
Alan Chalmers

Alan Chalmers reports that progress was made at a conference on the Council of Europe's proposed MEDICRIME convention, despite the controversy surrounding the World Health Organization's IMPACT initiative.

The latest events in the battle against counterfeiting (or falsification) of drugs and medical devices have left countries divided on how best to move forward...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36